Christopher Richard's Form 4 filing
Lexaria Bioscience Corp. (LEXX) · filed Dec 3, 2024
- Accession no.
- 0001348362-24-000006
- Filed
- Dec 3, 2024
- Trade date
- Dec 2-3, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $118.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christopher RichardCIK 0001271244 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | common shares | PPurchaseAcquired | +22,828 | $2.24 | +$51,134.72 | 22,828 | Direct | |
| Dec 3, 2024 | common shares | PPurchaseAcquired | +27,172 | $2.47 | +$67,114.84 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.